This document provides an overview and analysis of the high costs of cancer drugs from the perspective of pharmaceutical companies. It includes a table of contents outlining the various topics to be discussed, such as an analysis of statements made by pharmaceutical companies in the media about pricing, the challenges faced by companies, and strategies adopted to overcome pricing barriers. Case studies are presented of pricing strategies implemented for certain drugs in different countries and regions. The report aims to provide insights for various professionals in the pharmaceutical industry dealing with issues like market access, pricing, and strategic planning as it relates to oncology drug costs.

1. Precision Research & Consulting Pvt. Ltd.
www.idatainsights.com
HIGH COST OF CANCER DRUGS –
PHARMA PERSPECTIVE
Releasing: August 2015

2. Precision Research & Consulting Pvt. Ltd. www.idatainsights.com
Table of Content (Draft)High Cost of Cancer Drugs – Pharma Perspective
1. Executive Summary
2. Introduction
 An Overview of Cancer Drug Prices
 Case Study 1: Chronic Myeloid Leukemia (CML) Drugs
Price Variation with Respect to Geography
 Case Study 2: Opdivo Pricing in Japan
 Case Study 3: Blincyto Pricing
 Various Stakeholder’s Opinion on the Reasons Behind
the High Cost of Cancer Drugs
3. Analysis of Pharma Statements in the Media
 Key Topics of Discussion by Pharma Spokespersons
(2013 onwards): Theme-wise Company Distribution
 Key Topics of Discussion by Pharma Spokespersons
(2013 onwards): Company-wise Theme Distribution
 Word Cloud
 Some Key Pharma Statements
4. Pharma Perspectives on High
Prices of Cancer Drugs
 Challenges Faced by Pharmaceutical Companies
 Strategies Adopted by Pharmaceutical Companies to
Overcome Pricing Barriers for Cancer Drugs
 Case Study 1: Dose Capping for AVASTIN in Germany
and Italy
 Case Study 2: NICE and Risk Sharing Agreements
 Case Study 3: Innovative Patient Assistance Program
(PAP) – Glivec International Patient Assistance Program
(GIPAP)
 Case Study 4: Innovative Patient Assistance Program
(PAP) - Zydelig Access Connect Program (ZACP)
 Case Study 5: Roche and Chinese Insurance Companies
Collaboration
 Case Study 6: Differential Pricing – Generics
 What is the opinion of top 10 oncology companies on high prices?
Which are the most recurring words in media?
 What are the trends in oncology drug pricing?
 How do pharmaceutical companies justify the high prices of
oncology drugs?
 What are the major challenges to overcoming the high prices of
oncology drugs, and the strategies to do so?
 Competitive Intelligence
 Market Access Strategists
 HEOR Strategists
 Business Intelligence
 Information Specialist
 Commercial/Customer
Insights
 Strategic Planning
 Market/Marketing Research
 Decision Analysis/Decision
Support
 Business Analytics
 New Product Planning/
Development
 Forecasting
 Librarian
 Brand Management/Product
Management
 Marketing
 Business Portfolio Planning
 Strategic/Business Analysis
 Business Development
 Licensing
 Technical Analysis
 Portfolio Management/
Planning
 Project Management
 Risk Management
 Research Planning
 Research & Development
 Regulatory
 Scientist
 Legal/Regulatory
 Outsourcing
 Manufacturing
REPORT HIGHLIGHTS
A MUST BUY FOR
Professional from the pharmaceutical, biotech, medical device and
diagnostics industries with responsibilities or involvement in the fol-
lowing areas:

3. Order Form
I wish to procure research report “High Cost of Cancer Drugs – Pharma Perspective” priced at Rs 80,000 / 1,500 USD.
I wish to procure research report “High Cost of Cancer Drugs – Pharma Perspective” priced at Rs 72,000 / 1,350 USD as I am wishing
to avail discount.
Note: 1. Additional INR 5000 / 100 USD for Hard Copy printing
2. 10% Discount till August 31st
2015
Name(BlockLetters)_______________________________________________________Designation_______________________
Company_____________________________________________________________________________________________
Mailing Address_________________________________________________________________________________________
Telephone_________________________________________ Mobile_______________________________________________
Fax_________________________________________E-mail____________________________________________________
Contact Details:
K Venkat
Tel: +91 - 11 - 45544187, 41630406
Mobile: +91 - 8527803963
venkat@idatainsights.com
research@idatainsights.com
Corporate Office:
Precision Research and Consulting Pvt. Ltd.
502, Vishwadeep Tower, District Centre,
Janak Puri, New Delhi - 110058
Phone - 011 - 45544187
www.idatainsights.com info@idatainsights.com
Wire Transfer details:
Beneficiary: Precision Research and Consulting Pvt. Ltd.
Bank Name: ICICI Bank Ltd.
Bank Account No.: 664305500082
IFSC Code: ICIC0006643
Swift Code: ICICINBBCTS
Bank Address: J-8, Vikas Puri, New Delhi - 110018 (INDIA)
For cheque/demand draft:
I am enclosing a cheque/demand draft of
INR/US$:
vide cheque/DD no.:
drawn on:
dated:
In favour of:
www.idatainsights.com
High Cost of Cancer Drugs – Pharma Perspective